Saltar al contenido
MilliporeSigma

Age-dependent neonatal intracerebral hemorrhage in plasminogen activator inhibitor 1 knockout mice.

Journal of neuropathology and experimental neurology (2014-04-09)
Philippe Leroux, Priscilla L Omouendze, Vincent Roy, Nathalie Dourmap, Bruno J Gonzalez, Carole Brasse-Lagnel, Peter Carmeliet, Isabelle Leroux-Nicollet, Stéphane Marret
RESUMEN

Intracerebral-intraventricular hemorrhages (ICH/IVH) in very preterm neonates are responsible for high mortality and subsequent disabilities. In humans, tissue plasminogen activator (t-PA) initiates fibrinolysis and activates endoluminal-endothelial receptors; dysfunction of the t-PA inhibitor (PAI-1) results in recurrent hemorrhages. We used PAI-1 knockout (PAI-1) mice to examine the role of t-PA in age-dependent intracranial hemorrhages as a possible model of preterm ICH/IVH. Intracortical injection of 2 μL of phosphate-buffered saline produced a small traumatic injury and a high rate of hemorrhage in PAI-1 pups at postnatal day 3 (P3) or P5, whereas it had no effect in wild-type neonates. This resulted in white matter and cortical lesions, ventricle enlargement, hyperlocomotion, and altered cortical levels of serotonin and dopamine in the adult PAI mice. N-methyl-D-aspartate receptor blockers, plasmin- and matrix metalloproteinases inhibitors reduced hemorrhage and tissue lesions. In contrast to P3 to P5, no significant hemorrhages were induced in P10 PAI-1 pups and there were no behavioral or neurochemical alterations in adulthood. These data suggest that microvascular immaturity up to P5 in mice is a determinant factor required for t-PA-dependent vascular rupture. Neonatal PAI-1 mice could be a useful ICH/IVH model for studying the ontogenic window of vascular immaturity and vascular protection against later neurodisabilities.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Aprotinina from bovine lung, lyophilized powder, 3-8 TIU/mg solid
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Aprotinina from bovine lung, saline solution, 3-7 TIU/mg protein
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
6-Aminocaproic acid, ≥99% (titration), powder
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Aprotinina from bovine lung, lyophilized powder, 3-8 TIU/mg solid, BioReagent, suitable for cell culture
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Aprotinina from bovine lung, lyophilized powder, 3-7 TIU/mg solid
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
6-Aminocaproic acid, BioUltra, ≥99%
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Aprotinina from bovine lung
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
6-Aminohexanoic acid, ≥98.5% (NT)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Aprotinina from bovine lung, BioUltra, 3-8 TIU/mg solid, ≥98% (SDS-PAGE)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Aprotinin solution, BRP, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Supelco
Aminocaproic acid, Pharmaceutical Secondary Standard; Certified Reference Material
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Aprotinin for system suitability, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Aminocaproic acid, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
6-Aminocaproic acid, SAJ special grade, ≥99.0%
En este momento no podemos mostrarle ni los precios ni la disponibilidad